文献速递精神分裂症与精神病性障碍

多巴胺拮抗剂与精神分裂症动态症状网络

Dopamine antagonists and dynamic symptom networks in schizophrenia.
PubMed 文献 · Br J Psychiatry · 2026-09-14

该研究汇总8项帕利哌酮6周随机对照试验、共2508例精神分裂症谱系障碍患者的数据,用面板图形向量自回归建模症状网络。结果显示抗精神病药治疗组全局症状网络连接度显著低于安慰剂组,且特定症状间连接减弱,尤以「缺乏自发性」对其他症状的影响下降最明显。

要点

  • 抗精神病药治疗6周可降低精神分裂症症状网络的全局连接度。
  • 治疗组「缺乏自发性」对其他症状的影响较安慰剂组减弱。
  • 有效治疗不仅减轻症状严重度,还破坏症状间的动态相互依赖。

核心结论

  • 抗精神病药治疗不仅降低症状严重度,还破坏症状间的动态相互依赖,提示有效治疗削弱适应不良的症状耦合。

研究设计与样本

  • 汇总8项评估帕利哌酮6周疗效的随机对照试验,共2508例精神分裂症谱系障碍患者。
  • 采用基于重抽样的置换检验比较网络层面与症状层面的连接度。

主要发现

  • 抗精神病药治疗组全局症状网络连接度显著低于安慰剂组(18.92 v. 26.52;S = 7.60;p < 0.001)。
  • 特定症状间连接减弱,最显著为「缺乏自发性」对其他症状的影响降低(0.97 v. 1.74;p < 0.001)。

关键数值与推荐

  • 全局症状网络连接度:治疗组18.92,安慰剂组26.52;S = 7.60;p < 0.001。
  • 「缺乏自发性」对其他症状的影响:治疗组0.97,安慰剂组1.74;p < 0.001。

临床怎么用

  • 评估抗精神病药疗效时,除症状严重度外可关注症状间耦合是否减弱。
  • 症状网络连接度或可作为理解临床改善机制与干预靶点的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The symptoms of psychotic disorders do not exist in isolation, but interact with one another as part of a dynamic network. For example, hallucinations may worsen mood, which may exacerbate hallucinations, creating self-reinforcing cycles. These symptom interactions have been shown to lead to the onset and maintenance of disorders. Effective treatments should therefore not only reduce overall symptom severity, but also disrupt these pathological interactions. Although antipsychotics are known to reduce symptom burden, their effects on the dynamic architecture of symptom networks remain unclear. AIMS: This study aims to characterise how 6 weeks of antipsychotic treatment alters the structure of temporal symptom networks in schizophrenia. METHOD: Data were pooled from 8 randomised controlled trials evaluating the efficacy of paliperidone over 6 weeks, in 2508 participants with schizophrenia spectrum disorders. Twenty symptoms assessed across four time points were modelled using a panel graphical vector autoregression approach. Temporal networks were estimated for treatment and placebo groups. Network-level and symptom-level connectivity were compared using resampling-based permutation tests. RESULTS: Antipsychotic treatment was associated with significantly lower global symptom network connectivity than placebo treatment (18.92 v. 26.52; S = 7.60; p < 0.001). Specific inter-symptom connections were attenuated, most notably a reduced influence of 'lack of spontaneity' on other symptoms (0.97 v. 1.74; p < 0.001). CONCLUSIONS: Antipsychotic treatment not only decreases symptom severity, but also disrupts dynamic interdependencies among symptoms. These findings suggest that effective treatment weakens maladaptive symptom coupling, offering new insights into the mechanisms of clinical improvement and potential targets for intervention.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kenny EA, Brand BA, Ebrahimi OV, et al. Dopamine antagonists and dynamic symptom networks in schizophrenia. Br J Psychiatry. 2026. PMID: 42734073. doi:10.1192/bjp.2026.10775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。